Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ralf Huss

Premium

Definiens has tapped Ralf Huss to serve as its chief medical officer. In this position, Huss will play a key role in expanding the company's reach in the image and data analysis market, the company said.

Huss is a surgical and anatomical pathologist with more than 20 years of training and experience in histopathology and cancer research. Prior to joining Definiens, he served as the global head of the histopathology and tissue biomarker arm at Roche Diagnostics. He also co-founded Apceth, a German biotech company, and he holds academic appointments at the Ludwig-Maximilians-University in Munich and the Wake Forest Institute for Regenerative Medicine.

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.